Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina 29425.
Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina 29425
J Neurosci. 2018 Oct 17;38(42):8956-8966. doi: 10.1523/JNEUROSCI.1332-18.2018. Epub 2018 Sep 5.
A single BDNF microinfusion into prelimbic (PrL) cortex immediately after the last cocaine self-administration session decreases relapse to cocaine-seeking. The BDNF effect is blocked by NMDAR antagonists. To determine whether synaptic activity in putative excitatory projection neurons in PrL cortex is sufficient for BDNF's effect on relapse, the PrL cortex of male rats was infused with an inhibitory Designer Receptor Exclusively Activated by Designer Drugs (DREADD) viral vector driven by an αCaMKII promoter. Immediately after the last cocaine self-administration session, rats were injected with clozapine-N-oxide 30 min before an intra-PrL BDNF microinfusion. DREADD-mediated inhibition of the PrL cortex blocked the BDNF-induced decrease in cocaine-seeking after abstinence and cue-induced reinstatement after extinction. Unexpectedly, DREADD inhibition of PrL neurons in PBS-infused rats also reduced cocaine-seeking, suggesting that divergent PrL pathways affect relapse. Next, using a cre-dependent retroviral approach, we tested the ability of DREADD inhibition of PrL projections to the NAc core or the paraventricular thalamic nucleus (PVT) to alter cocaine-seeking in BDNF- and PBS-infused rats. Selective inhibition of the PrL-NAc pathway at the end of cocaine self-administration blocked the BDNF-induced decrease in cocaine-seeking but had no effect in PBS-infused rats. In contrast, selective inhibition of the PrL-PVT pathway in PBS-infused rats decreased cocaine-seeking, and this effect was prevented in BDNF-infused rats. Thus, activity in the PrL-NAc pathway is responsible for the therapeutic effect of BDNF on cocaine-seeking whereas inhibition of activity in the PrL-pPVT pathway elicits a similar therapeutic effect in the absence of BDNF. The major issue in cocaine addiction is the high rate of relapse. However, the neuronal pathways governing relapse remain unclear. Using a pathway-specific chemogenetic approach, we found that BDNF differentially regulates two key prelimbic pathways to guide long-term relapse. Infusion of BDNF in the prelimbic cortex during early withdrawal from cocaine self-administration decreases relapse that is prevented when neurons projecting from the prelimbic cortex to the nucleus accumbens core are inhibited. In contrast, BDNF restores relapse when neurons projecting from the prelimbic cortex to the posterior paraventricular thalamic nucleus are inhibited. This study demonstrates that two divergent cortical outputs mediate relapse that is regulated in opposite directions by infusing BDNF in the prelimbic cortex during early withdrawal from cocaine.
单次 BDNF 微量注射到可卡因自我给药疗程结束后即刻的前额皮质(PrL)可减少可卡因觅药的复吸。BDNF 的作用可被 NMDA 受体拮抗剂阻断。为了确定 PrL 皮质中假定的兴奋性投射神经元的突触活动是否足以产生 BDNF 对复吸的影响,雄性大鼠的 PrL 皮质被αCaMKII 启动子驱动的抑制性 Designer Receptor Exclusively Activated by Designer Drugs(DREADD)病毒载体进行了微量注射。在可卡因自我给药疗程结束后即刻,在 PrL 内进行 BDNF 微量注射前 30 分钟,大鼠被注射氯氮平-N-氧化物。DREADD 介导的 PrL 皮质抑制阻断了戒断后 BDNF 诱导的可卡因觅药减少和消退后线索诱导的复吸。出乎意料的是,在 PBS 输注大鼠中 DREADD 抑制 PrL 神经元也减少了可卡因觅药,这表明不同的 PrL 途径会影响复吸。接下来,使用 Cre 依赖性逆转录病毒方法,我们测试了 DREADD 抑制 PrL 投射到 NAc 核心或室旁丘脑核(PVT)以改变 BDNF 和 PBS 输注大鼠中的可卡因觅药的能力。在可卡因自我给药结束时选择性抑制 PrL-NAc 通路阻断了 BDNF 诱导的可卡因觅药减少,但在 PBS 输注大鼠中没有影响。相比之下,在 PBS 输注大鼠中选择性抑制 PrL-PVT 通路可减少可卡因觅药,而在 BDNF 输注大鼠中则可防止该作用。因此,PrL-NAc 通路的活动负责 BDNF 对可卡因觅药的治疗作用,而抑制 PrL-pPVT 通路的活动在没有 BDNF 的情况下会产生类似的治疗作用。可卡因成瘾的主要问题是复吸率高。然而,支配复吸的神经元通路仍不清楚。使用通路特异性化学遗传方法,我们发现 BDNF 差异调节两个关键的前额叶皮质通路以指导长期复吸。在可卡因自我给药疗程结束后的早期从可卡因中撤出时,将 BDNF 输注到前额皮质中可减少复吸,而当抑制从前额皮质投射到伏隔核核心的神经元时,复吸则被阻断。相比之下,当抑制从前额皮质投射到后室旁丘脑核的神经元时,BDNF 会恢复复吸。这项研究表明,两个不同的皮质输出介导复吸,而在可卡因撤出早期将 BDNF 输注到前额皮质中可调节这两个输出以相反的方向调节复吸。